Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tuberculosis | 2 | 2025 | 9 | 1.810 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2021 | 12 | 0.890 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2024 | 4 | 0.890 |
Why?
|
| Cytokines | 2 | 2019 | 80 | 0.680 |
Why?
|
| Immunosuppressive Agents | 1 | 2018 | 31 | 0.550 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 120 | 0.530 |
Why?
|
| Microscopic Polyangiitis | 1 | 2016 | 1 | 0.500 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2016 | 2 | 0.500 |
Why?
|
| Humans | 9 | 2025 | 6794 | 0.380 |
Why?
|
| Aged | 2 | 2025 | 1539 | 0.260 |
Why?
|
| Vietnam | 1 | 2025 | 1 | 0.240 |
Why?
|
| Female | 4 | 2025 | 4060 | 0.230 |
Why?
|
| Systems Analysis | 1 | 2024 | 1 | 0.220 |
Why?
|
| Child, Preschool | 1 | 2025 | 258 | 0.220 |
Why?
|
| Pandemics | 1 | 2025 | 87 | 0.220 |
Why?
|
| Child | 1 | 2025 | 524 | 0.210 |
Why?
|
| Young Adult | 1 | 2025 | 567 | 0.200 |
Why?
|
| Male | 4 | 2025 | 3671 | 0.200 |
Why?
|
| Adolescent | 1 | 2025 | 869 | 0.190 |
Why?
|
| Macrophages | 2 | 2020 | 40 | 0.190 |
Why?
|
| Middle Aged | 2 | 2025 | 2108 | 0.180 |
Why?
|
| Biological Products | 1 | 2021 | 6 | 0.170 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2020 | 29 | 0.170 |
Why?
|
| Atherosclerosis | 1 | 2021 | 39 | 0.160 |
Why?
|
| Streptolysins | 1 | 2020 | 2 | 0.160 |
Why?
|
| Hydroxycholesterols | 1 | 2020 | 2 | 0.160 |
Why?
|
| Interferons | 1 | 2020 | 3 | 0.160 |
Why?
|
| Phagocytes | 1 | 2020 | 2 | 0.160 |
Why?
|
| Bacterial Infections | 1 | 2020 | 12 | 0.160 |
Why?
|
| Bacterial Toxins | 1 | 2020 | 6 | 0.160 |
Why?
|
| Toll-Like Receptors | 1 | 2020 | 16 | 0.160 |
Why?
|
| Adult | 1 | 2025 | 2113 | 0.160 |
Why?
|
| Malignant Carcinoid Syndrome | 1 | 2019 | 1 | 0.150 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 11 | 0.150 |
Why?
|
| Autoimmune Diseases | 1 | 2019 | 9 | 0.150 |
Why?
|
| Isotope Labeling | 1 | 2018 | 2 | 0.150 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 30 | 0.150 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 172 | 0.150 |
Why?
|
| Fatty Acids | 1 | 2018 | 25 | 0.140 |
Why?
|
| Models, Biological | 1 | 2018 | 64 | 0.140 |
Why?
|
| Mutation | 1 | 2019 | 97 | 0.140 |
Why?
|
| Vasculitis | 1 | 2016 | 3 | 0.130 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 79 | 0.120 |
Why?
|
| Animals | 5 | 2020 | 1875 | 0.110 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 2 | 2010 | 2 | 0.100 |
Why?
|
| Mice | 4 | 2020 | 746 | 0.100 |
Why?
|
| Lymphoid Tissue | 1 | 2010 | 3 | 0.080 |
Why?
|
| Killer Cells, Natural | 1 | 2010 | 35 | 0.080 |
Why?
|
| Mice, Transgenic | 2 | 2020 | 59 | 0.080 |
Why?
|
| Cell Line | 2 | 2020 | 124 | 0.080 |
Why?
|
| Natural Killer T-Cells | 1 | 2008 | 2 | 0.070 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2008 | 12 | 0.070 |
Why?
|
| Intestinal Mucosa | 1 | 2008 | 17 | 0.070 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2008 | 33 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2008 | 53 | 0.070 |
Why?
|
| Bacteria | 2 | 2020 | 9 | 0.060 |
Why?
|
| Mice, Knockout | 2 | 2020 | 150 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2019 | 94 | 0.060 |
Why?
|
| Homeostasis | 2 | 2018 | 40 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2018 | 258 | 0.050 |
Why?
|
| Immunoglobulin A | 1 | 2020 | 4 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2020 | 10 | 0.040 |
Why?
|
| Intravital Microscopy | 1 | 2020 | 1 | 0.040 |
Why?
|
| Steroid Hydroxylases | 1 | 2020 | 3 | 0.040 |
Why?
|
| Cell Membrane Permeability | 1 | 2020 | 7 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 10 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2020 | 10 | 0.040 |
Why?
|
| Bacterial Proteins | 1 | 2020 | 10 | 0.040 |
Why?
|
| Coronary Angiography | 1 | 2020 | 71 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2020 | 54 | 0.040 |
Why?
|
| Interleukins | 2 | 2010 | 8 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2020 | 234 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 231 | 0.040 |
Why?
|
| Heredity | 1 | 2019 | 2 | 0.040 |
Why?
|
| Carbon | 1 | 2018 | 2 | 0.040 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2018 | 4 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 63 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2020 | 246 | 0.040 |
Why?
|
| Phenotype | 1 | 2019 | 91 | 0.040 |
Why?
|
| Risk Factors | 1 | 2021 | 767 | 0.040 |
Why?
|
| Inflammation | 1 | 2018 | 143 | 0.030 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2010 | 3 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2010 | 2 | 0.020 |
Why?
|
| Interleukin-15 | 1 | 2010 | 2 | 0.020 |
Why?
|
| Interleukin-7 | 1 | 2010 | 2 | 0.020 |
Why?
|
| Intestines | 1 | 2010 | 7 | 0.020 |
Why?
|
| Interleukin-12 | 1 | 2010 | 7 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2010 | 23 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2010 | 25 | 0.020 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2010 | 6 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2010 | 57 | 0.020 |
Why?
|
| Antigens, Ly | 1 | 2008 | 1 | 0.020 |
Why?
|
| Peyer's Patches | 1 | 2008 | 1 | 0.020 |
Why?
|
| Natural Cytotoxicity Triggering Receptor 1 | 1 | 2008 | 1 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2008 | 101 | 0.020 |
Why?
|